Litcius/Paper detail

Control of Dendritic Cell Function Within the Tumour Microenvironment

Yukti Hari Gupta, Abida Khanom, Sophie E. Acton

2022Frontiers in Immunology65 citationsDOIOpen Access PDF

Abstract

The tumour microenvironment (TME) presents a major block to anti-tumour immune responses and to effective cancer immunotherapy. The inflammatory mediators such as cytokines, chemokines, growth factors and prostaglandins generated in the TME alter the phenotype and function of dendritic cells (DCs) that are critical for a successful adaptive immune response against the growing tumour. In this mini review we discuss how tumour cells and the surrounding stroma modulate DC maturation and trafficking to impact T cell function. Fibroblastic stroma and the associated extracellular matrix around tumours can also provide physical restrictions to infiltrating DCs and other leukocytes. We discuss interactions between the inflammatory TME and infiltrating immune cell function, exploring how the inflammatory TME affects generation of T cell-driven anti-tumour immunity. We discuss the open question of the relative importance of antigen-presentation site; locally within the TME versus tumour-draining lymph nodes. Addressing these questions will potentially increase immune surveillance and enhance anti-tumour immunity.

Topics & Concepts

Tumor microenvironmentImmune systemDendritic cellImmunotherapyChemokineAntigen presentationBiologyCancer immunotherapyImmunologyT cellAcquired immune systemStromal cellCancer researchImmunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Control of Dendritic Cell Function Within the Tumour Microenvironment | Litcius